New Jersey joins seven other states in promulgating an Aid in Dying for the Terminally Ill statute, sponsored by Senator Kip Bateman (R16) and Assemblyman John Burzichelli (D3), signed into law by Governor Phil Murphy and enacted on August 1, 2019. The law allows terminally ill New Jersey adults who are within 6 months of dying to end their lives peacefully, with dignity, and at their own discretion.
In light of its societal significance for New Jersey, the Bloustein School, with assistance from MDAdvantage, the Rutgers Graduate Society of Healthcare Leaders and the Future Healthcare Administrators of Rutgers, will host, ” “Implications of the New Jersey Aid in Dying Act for Healthcare Providers and Administrators” on Wednesday, October 30 at 5:00 p.m. The school is convening a distinguished panel of our state’s healthcare leaders to participate in an open dialogue about the implications this law may have for physicians, nurses, pharmacists, healthcare administrators, related healthcare professionals and society at large.
Hon. Paul W. Armstrong, JSC (ret). MA, JD, LLM, Senior Policy Fellow, Edward J. Bloustein School of Planning and Public Policy, Rutgers University will moderate the panel. Panelists will include (confirmed) Hon. Christopher (Kip) Bateman (R 16), New Jersey State Senate, Senate Sponsor for Legislation; Dr. Andrew L. Falzon, M.D., Chief State Medical Examiner, New Jersey Department of Health ; Hon. Cathy D. Bennett, JD, President & CEO, New Jersey Hospital Association; Joseph Fennelly, MD, Chair Emeritus, Bioethics Committee of the Medical Society of New Jersey; and T. Patrick Hill, BD, MA, PhD, Associate Teaching Professor, Ethics, Edward J. Bloustein School of Planning and Public Policy. Panelists will discuss the legislation and implications for members of the healthcare community.
Hon. Judith M. Persichilli, R.N., B.S.N., M.A., Commissioner, New Jersey Department of Health, had been invited, but is unable to attend. Dr. Falzon has accepted the invitation in her stead.